Efficacy of low-dose risperidone in combination with sertraline in first-episode drug-naïve patients with schizophrenia: a randomized controlled open-label study

OBJECTIVE: Despite advances in pharmacology, the treatment of schizophrenia (SZ) remains a challenge due to relapse after antipsychotic discontinuation and multiple adverse effects of antipsychotics. We hypothesized that a low dose of risperidone in combination with sertraline would reduce serious a...

Descripción completa

Detalles Bibliográficos
Autores principales: Lang, Xiaoe, Xue, Mei, Zang, Xiaocui, Wu, Fengchun, Xiu, Meihong, Zhang, Xiangyang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10318661/
https://www.ncbi.nlm.nih.gov/pubmed/37403159
http://dx.doi.org/10.1186/s12967-023-04272-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10318661/
https://www.ncbi.nlm.nih.gov/pubmed/37403159
http://dx.doi.org/10.1186/s12967-023-04272-7

Ejemplares similares